| 
			
 | 
			
    | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			Topics | 
	
		| 
			
 | 
			Glioblastoma
			| Treatment | Targeted therapy | Overview | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			Home
			> Publications
			> Topics
			> Glioblastoma
			>
			Treatment
			>
			Targeted
			therapy >
			Overview | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			Shikalov A, Koman I, Kogan NM.Targeted
			Glioma Therapy-Clinical Trials and Future
			Directions.
 Pharmaceutics.
			2024 Jan 11;16(1):100. doi:
			10.3390/pharmaceutics16010100. PMID:
			38258110. Review. ˍ
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			Jacome MA, Wu Q, Piña Y, Etame AB. Evolution
			of Molecular Biomarkers and Precision Molecular Therapeutic
			Strategies in Glioblastoma.
 Cancers
			(Basel). 2024 Oct 29;16(21):3635. doi:
			10.3390/cancers16213635. PMID:
			39518074. Review. ˍ
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			Satish S, Athavale M, Kharkar PS. Targeted
			therapies for Glioblastoma multiforme (GBM): State-of-the-art and
			future prospects.
 Drug
			Dev Res. 2024 Nov 1;85(7):e22261. doi:
			10.1002/ddr.22261. PMID:
			39485272. Review˰ ˍ
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			Rusak A, Wiatrak B, Krawczyńska K, Górnicki T,
			Zagórski K, Zadka Ł, Fortuna W. Starting
			points for the development of new targeted therapies for
			glioblastoma multiforme.
 Transl
			Oncol. 2024 Nov 11;51:102187. doi:
			10.1016/j.tranon.2024.102187. PMID:
			39531784. Review. ˍ
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			Ippen FM, Scherm A, Kessler T, Hau P, Agkatsev S, Baurecht H, Wick
			W, Knüttel H, Leitzmann MF, Seliger-Behme C. Targeted
			agents in patients with progressive glioblastoma-A systematic
			meta-analysis of randomized clinical trials.
 Cancer
			Med. 2024 Jun 21;13(12):e7362. doi:
			10.1002/cam4.7362. PMID:
			39618405. Meta-analysis. ˍ
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			Singh G, Rohit, Kumar P, Aran KR. Targeting
			EGFR and PI3K/mTOR pathways in glioblastoma: innovative
			therapeutic approaches.
 Med
			Oncol. 2025 Mar 10;42(4):97. doi:
			10.1007/s12032-025-02652-1. PMID:
			40064710. Review˰ ˍ
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			*Tang J, Karbhari N, Campian JL. Therapeutic
			Targets in Glioblastoma: Molecular Pathways, Emerging Strategies,
			and Future Directions.
 Cells.
			2025 Mar 26;14(7):494. doi:
			10.3390/cells14070494. PMID:
			40214448. Review. ˍ
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			
 | 
	
		| 
			
 | 
			
 |